Affordable generic medicine for an AIDS or cancer patient in the developing world can mean life or death. Unfortunately, drug giant Novartis is suing to stop the sale of more affordable generic medicine and deny those suffering from treatable diseases the medicine they rely on. If they are successful, the cost of treatments will skyrocket out of reach for the majority of people in the developing world who rely on generic medicine. 

India is one of the few developing countries with the production capacity to manufacture quality-assured generic medicines, but Novartis is trying to stop their production. They’ve taken their case to the Indian Supreme Court, and if Novartis wins, it could mean millions of lives at stake around the world.

As the case now opens before the Indian Supreme Court, join Doctors Without Borders/Médecins Sans Frontières (MSF) and tell Novartis that people matter more than profits.